Healthcare

THERAVANCE BIOPHARMA INC

Ticker: TBPH
Exchange: US
Composite FIGI: BBG004HK6YX1

Total Alternative Signals

2signals tracked

Weighted Sentiment

-0.08weighted index

Avg Materiality Score

2.5/ 5.0 scale

Signal Distribution

0|2|0

Alternative Data Signal Feed

Real-Time Ingestion Active

Unlock Alternative Signals Feed

Access the complete, parsed materiality analysis, long-term investment theses, and direct feed links for THERAVANCE BIOPHARMA INC. Programmatic API and Webhooks available.

Talent PivotNeutral
Filing Date: 2026-06-16

Signal Event Report - FIGI BBG004HK6YX1

A Form 144 was filed on June 15, 2026, indicating a proposed sale of securities by an affiliate or insider of Theravance Biopharma Inc. This suggests a potential reduction in insider holdings.

Quantitative Investment Thesis

This filing signals a potential future sale of shares by an insider or affiliate. While not a direct sale, it could be perceived as a slight negative if the volume is significant, indicating a potential lack of confidence or diversification strategy.

Materiality & Sentiment Scores
Sentiment: -0.2
Materiality: 2 / 5
Source Document: https://www.sec.gov/Archives/edgar/data/1583107/0001950047-26-006154-index.htm
Talent PivotNeutral
Filing Date: 2026-06-15

Signal Event Report - FIGI BBG004HK6YX1

Theravance Biopharma filed an 8-K reporting on matters submitted to a vote of security holders, which could include significant corporate governance decisions or changes in leadership.

Quantitative Investment Thesis

Investors should monitor the details of the shareholder vote to understand potential shifts in corporate governance or leadership that could influence the company's strategic direction and long-term performance.

Materiality & Sentiment Scores
Sentiment: 0
Materiality: 3 / 5
Source Document: https://www.sec.gov/cgi-bin/browse-edgar?action=getcompany&CIK=0001583107&type=&dateb=&scd=company